Catalyst Wire Dossier Catalyst Wire Dossier

GLPG0634 (filgotinib)

filgotinib · Galapagos NV
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for GLPG0634 (filgotinib), covering 2011-03-24 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease [Phase 2]

See pricing